Cowen Remains Bullish On Abbott Labs (ABT) Despite A Year Ahead Of Tough Comps
Tweet Send to a Friend
Cowen analyst Joshua Jennings reiterated an Outperform rating and $86.00 price target on Abbott Labs (NYSE: ABT) ahead of 1Q’19 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
